Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Increased hepatic putrescine levels as a new potential factor related to the progression of metabolic dysfunction‐associated steatotic liver disease

The Journal of Pathology(2024)10.1002/path.6330Source: DataRank Database

Increased hepatic putrescine levels as a new potential factor related to the progression of metabolic dysfunction‐associated steatotic liver disease is a research paper published in The Journal of Pathology (2024). On theSindex it has a DataRank of 0. It has been cited 16 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access16 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)Impact (FWCI 5.59)OA: bronzeTopics (58)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (14)

María Antonia Martínez‐Sánchez ORCID,Marta Sierra‐Cruz ORCID,Ana Lambertos ORCID,Sara Rico‐Chazarra,Alba Oliva‐Bolarín ORCID

Live enrichment

PubMed:39022853 PMC:PMC11300153 OpenAlex:https://openalex.org/W4400786357

National Institutes of Health

Grant: R01DK131038

National Institutes of Health

Grant: R03DK129419

Instituto de Salud Carlos III

Grant: CP19/00098

Instituto de Salud Carlos III

Grant: CP23/00051

Instituto de Salud Carlos III

Grant: FI21/00003

Instituto de Salud Carlos III

Grant: PI20/00505

Instituto de Salud Carlos III

Grant: PI23/00171

FWCI

5.59

Citation Percentile

1.0%

Citation Trend

2024

2025

2026

bronzeLicense: http://onlinelibrary.wiley.com/termsAndConditions#vor

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/path.6330

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/path.6330

publisherhttps://pathsocjournals.onlinelibrary.wiley.com/doi/pdf/10.1002/path.6330

journalhttps://doi.org/10.1002/path.6330

repositoryhttps://pubmed.ncbi.nlm.nih.gov/39022853

Fields of Study

Cannabis and Cannabinoid ResearchDiet, Metabolism, and DiseasePolyamine Metabolism and ApplicationsAnimalsHumansPutrescineOrnithine DecarboxylaseLiverDisease ProgressionMaleMice, Inbred C57BLFatty LiverMiceDisease Models, AnimalFemaleMiddle AgedObesityHep G2 CellsAdult

MeSH Terms

AdultAnimalsDisease Models, AnimalFatty LiverFemaleHumansLiverMaleMice, Inbred C57BLMiddle AgedObesityOrnithine DecarboxylasePutrescineDisease ProgressionMiceHep G2 Cells

Keywords

SteatosisInternal medicinePutrescineEndocrinologySteatohepatitisLiver diseaseFatty liverMedicineChronic liver diseasePopulationInflammationSpermidineBiologyCirrhosisDiseaseBiochemistryEnzymeObesityPolyamineOrnithine decarboxylaseLiver MetabolismMetabolic Dysfunction‐associated Steatotic Liver DiseaseMetabolic Dysfunction‐associated Steatohepatitis

Sustainable Development Goals

SDG 0: Good health and well-being